These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28218937)

  • 1. Academic Detailing Pilot for Naloxone Prescribing Among Primary Care Providers in San Francisco.
    Behar E; Rowe C; Santos GM; Santos N; Coffin PO
    Fam Med; 2017 Feb; 49(2):122-126. PubMed ID: 28218937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis.
    Bounthavong M; Harvey MA; Wells DL; Popish SJ; Himstreet J; Oliva EM; Kay CL; Lau MK; Randeria-Noor PP; Phillips AG; Christopher MLD
    J Am Pharm Assoc (2003); 2017; 57(2S):S68-S72. PubMed ID: 28089521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.
    Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A
    Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.
    Bounthavong M; Suh K; Christopher MLD; Veenstra DL; Basu A; Devine EB
    Res Social Adm Pharm; 2020 Aug; 16(8):1033-1040. PubMed ID: 31706950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of virtual to in-person academic detailing on naloxone prescribing rates at three U.S. Veterans Health Administration regional networks.
    Bounthavong M; Shayegani R; Manning JM; Marin J; Spoutz P; Hoffman JD; Harvey MA; Himstreet JE; Kay CL; Freeman BA; Almeida A; Christopher MLD
    Int J Med Inform; 2022 May; 161():104712. PubMed ID: 35196600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of naloxone prescribing patterns due to educational outreach conducted by full-time and part-time academic detailers at the U.S. Veterans Health Administration.
    Bounthavong M; Harvey MA; Kay CL; Lau MK; Wells DL; Himstreet JE; Popish SJ; Oliva EM; Christopher MLD
    J Am Pharm Assoc (2003); 2020; 60(4):639-646. PubMed ID: 31866383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain.
    Behar E; Rowe C; Santos GM; Coffa D; Turner C; Santos NC; Coffin PO
    J Gen Intern Med; 2017 Mar; 32(3):291-295. PubMed ID: 27815762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs.
    Bounthavong M; Christopher MLD; Veenstra DL; Basu A; Devine EB
    J Pharm Pract; 2023 Jun; 36(3):514-522. PubMed ID: 34766510
    [No Abstract]   [Full Text] [Related]  

  • 9. Naloxone Academic Detailing: Role of Community Outreach Teaching.
    Abd-Elsayed A; Albert CA; Fischer M; Anderson B
    Curr Pain Headache Rep; 2018 Aug; 22(11):72. PubMed ID: 30151695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone Counseling for Harm Reduction and Patient Engagement.
    Han JK; Hill LG; Koenig ME; Das N
    Fam Med; 2017 Oct; 49(9):730-733. PubMed ID: 29045991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing an overdose education and naloxone distribution program in a health system.
    Devries J; Rafie S; Polston G
    J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organization.
    Bhargava V; Greg ME; Shields MC
    J Manag Care Pharm; 2010; 16(6):384-92. PubMed ID: 20635829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of an academic detailing intervention in primary care on the prescribing of non-steroidal anti-inflammatory drugs.
    Langaas HC; Hurley E; Dyrkorn R; Spigset O
    Eur J Clin Pharmacol; 2019 Apr; 75(4):577-586. PubMed ID: 30596208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain.
    Coffin PO; Behar E; Rowe C; Santos GM; Coffa D; Bald M; Vittinghoff E
    Ann Intern Med; 2016 Aug; 165(4):245-52. PubMed ID: 27366987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Academic detailing as a method to improve general practitioners' drug prescribing in type 2 diabetes: evaluation of changes in prescribing.
    Langaas HC; Salvesen Ø; Dyrkorn R; Blix HS; Spigset O
    Scand J Prim Health Care; 2023 Sep; 41(3):224-231. PubMed ID: 37326464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
    Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
    J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist-led academic detailing intervention in primary care: a mixed methods feasibility study.
    Riordan DO; Hurley E; Sinnott C; Galvin R; Dalton K; Kearney PM; Halpin JD; Byrne S
    Int J Clin Pharm; 2019 Apr; 41(2):574-582. PubMed ID: 30666611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Healthcare System-Level Intervention to Increase Naloxone Availability for Patients With Opioid Prescriptions.
    Siff JE; Margolius D; Papp J; Boulanger B; Watts B
    Am J Addict; 2021 Mar; 30(2):179-182. PubMed ID: 33378097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and acceptability of virtual academic detailing on opioid prescribing.
    Smart MH; Mandava MR; Lee TA; Pickard AS
    Int J Med Inform; 2021 Mar; 147():104365. PubMed ID: 33360790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.